ProstaGene
Philadelphia, US · Founded 2011 · Delaware LLC
Founders & leadership
ProstaGene was founded in 2011 by Richard Pestell.
RP
Richard PestellFounder
Board
DM
Dan MatthiasBoard director
Reported raises · per SEC filings
Form D private placements$1.2M disclosed across 2 rounds · 2015–2016
▶$400KraisedApr 2016 · 4 investors · PharmaceuticalsRule 506(b)
▶$400KraisedApr 2016 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard PestellExecutive Officer, Director
- Dan MatthiasExecutive Officer, Director
- Offering amount
- $1.4M
- Amount sold
- $400K
- Minimum investment
- $100K
- First sale
- Apr 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$825KraisedMay 2015 · 6 investors · PharmaceuticalsRule 506(b)
▶$825KraisedMay 2015 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Dan MatthiasDirector
- Richard PestellExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $825K
- Minimum investment
- $100K
- First sale
- Feb 2015
- Incorporated
- Limited Liability Company, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded ProstaGene?
- ProstaGene was founded by Richard Pestell in 2011.
- How much funding has ProstaGene raised?
- ProstaGene has disclosed $1.2M raised across 2 rounds.
- Where is ProstaGene headquartered?
- ProstaGene is headquartered in Philadelphia, US.